Early Metformin Cuts Long COVID Risk
(MedPage Today) -- Early treatment with metformin reduced the risk of long COVID among outpatients, according to secondary results of a negative phase III trial.
In the COVID-OUT study of over 1,100 randomized participants, the cumulative incidence...
Source: MedPage Today Public Health - Category: American Health Source Type: news